Literature DB >> 26348541

NF-κB/RelA and Nrf2 cooperate to maintain hepatocyte integrity and to prevent development of hepatocellular adenoma.

Ulrike A Köhler1, Friederike Böhm2, Frank Rolfs1, Michèle Egger2, Thorsten Hornemann3, Manolis Pasparakis4, Achim Weber5, Sabine Werner6.   

Abstract

BACKGROUND & AIMS: The liver is frequently challenged by toxins and reactive oxygen species. Therefore, hepatocytes require cytoprotective strategies to cope with these insults. Since the transcription factors Nrf2 and NF-κB regulate the cellular antioxidant defense system and important survival pathways, we determined their individual and overlapping functions in the liver.
METHODS: We generated mice lacking Nrf2 and the NF-κB RelA/p65 subunit in hepatocytes and we analyzed their liver by using histopathology, immunohistochemistry, quantitative RT-PCR, Western blot and Oxyblot analysis. Human inflammatory hepatocellular adenomas (iHCA) were analyzed by immunohistochemistry.
RESULTS: Loss of either Nrf2 or NF-κB/RelA had only a minor effect on liver homeostasis, but the double knockout mice spontaneously developed liver inflammation and fibrosis. Upon aging, more than one-third of the female double mutant mice developed tumors, which histologically resemble human iHCA, a tumor that predominantly occurs in women. The mouse tumors also recapitulated the immunohistochemical marker profile characteristic for human iHCA. Moreover, pNRF2 and NF-κB RelA/p65 was not detectable in the nuclei of iHCA tumor cells. The mouse phenotype was not due to a synergistic effect of both transcription factors on cytoprotective Nrf2 target genes. Rather, loss of Nrf2 or NF-κB/RelA altered the expression of different genes, and the combination of these alterations likely affects liver homeostasis in the double mutant mice.
CONCLUSIONS: Our results provide genetic evidence for a functional cross-talk of Nrf2 and NF-κB/RelA in hepatocytes, which protects the liver from necrosis, inflammation and fibrosis. Furthermore, the double mutant mice represent a valuable animal model for iHCA.
Copyright © 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hepatocellular adenoma; Inflammation; Liver fibrosis; NF-κB; Nrf2

Mesh:

Substances:

Year:  2015        PMID: 26348541     DOI: 10.1016/j.jhep.2015.08.033

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  18 in total

Review 1.  Impact of host genetic polymorphisms on vaccine induced antibody response.

Authors:  Janina E Linnik; Adrian Egli
Journal:  Hum Vaccin Immunother       Date:  2016-01-25       Impact factor: 3.452

Review 2.  Dysregulation of redox pathways in liver fibrosis.

Authors:  Natalie J Torok
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-08-25       Impact factor: 4.052

Review 3.  NF-κB, inflammation, immunity and cancer: coming of age.

Authors:  Koji Taniguchi; Michael Karin
Journal:  Nat Rev Immunol       Date:  2018-01-22       Impact factor: 53.106

Review 4.  Current Approaches in the Management of Hepatic Adenomas.

Authors:  Diamantis I Tsilimigras; Amir A Rahnemai-Azar; Ioannis Ntanasis-Stathopoulos; Maria Gavriatopoulou; Demetrios Moris; Eleftherios Spartalis; Jordan M Cloyd; Sharon M Weber; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2018-08-14       Impact factor: 3.452

5.  Schisandrin B attenuates CCl4-induced liver fibrosis in rats by regulation of Nrf2-ARE and TGF-β/Smad signaling pathways.

Authors:  Qingshan Chen; Hai Zhang; Yan Cao; Ying Li; Sen Sun; Junping Zhang; Guoqing Zhang
Journal:  Drug Des Devel Ther       Date:  2017-07-26       Impact factor: 4.162

6.  Systematic revelation of the protective effect and mechanism of Cordycep sinensis on diethylnitrosamine-induced rat hepatocellular carcinoma with proteomics.

Authors:  Pei-Wen Wang; Yu-Chiang Hung; Wen-Tai Li; Chau-Ting Yeh; Tai-Long Pan
Journal:  Oncotarget       Date:  2016-09-13

7.  Tanshinol ameliorates CCl4-induced liver fibrosis in rats through the regulation of Nrf2/HO-1 and NF-κB/IκBα signaling pathway.

Authors:  Rong Wang; Jing Wang; Fuxing Song; Shengnan Li; Yongfang Yuan
Journal:  Drug Des Devel Ther       Date:  2018-05-17       Impact factor: 4.162

Review 8.  HCV and Oxidative Stress: Implications for HCV Life Cycle and HCV-Associated Pathogenesis.

Authors:  Regina Medvedev; Daniela Ploen; Eberhard Hildt
Journal:  Oxid Med Cell Longev       Date:  2016-02-03       Impact factor: 6.543

Review 9.  Pluripotent Stem Cell-Derived Human Tissue: Platforms to Evaluate Drug Metabolism and Safety.

Authors:  Jose Meseguer-Ripolles; Salman R Khetani; Javier G Blanco; Mairi Iredale; David C Hay
Journal:  AAPS J       Date:  2017-12-21       Impact factor: 4.009

Review 10.  Role of the NFκB-signaling pathway in cancer.

Authors:  Longzheng Xia; Shiming Tan; Yujuan Zhou; Jingguan Lin; Heran Wang; Linda Oyang; Yutong Tian; Lu Liu; Min Su; Hui Wang; Deliang Cao; Qianjin Liao
Journal:  Onco Targets Ther       Date:  2018-04-11       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.